medline.ch Onkologie Gynäkologische Tumoren

	The co-design, development, and preliminary evaluation of a comprehensive breast cancer risk report incorporating polygenic risk information. Eur J Hum Genet Hanley MN, Purvis R, Limb S, Saya S, Bickerstaffe A, Wheeler J, Shen Y, Hilton M, Dai M, Liu E, Forbes Shepherd R, James PA, Forrest LE. PMID: 42538389 [PubMed - as supplied by publisher]
	A transcriptional signature of resting mast cells is associated with improved disease outcome in HR(+)HER2(-) breast cancer. Genes Immun Kirchmair A, Galassi C, García-Torralba E, Trajanoski Z, Buqué A, Galluzzi L. PMID: 42538366 [PubMed - as supplied by publisher]
	Codesign and implementation of a Tai Chi intervention for managing the fatigue, sleep disturbance and depression symptom cluster in breast cancer survivors in regional Australia: a feasibility study protocol. BMJ Open Skinner S, Kwok WH, Tan JB, Wang T, Bressington D, Yao L, Nic Giolla Easpaig B. PMID: 42538108 [PubMed - indexed for MEDLINE]
	A Multicenter Non-Inferiority Randomized Controlled Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Conventional Dual Tracer Versus Superparamagnetic Iron Oxide. World J Surg Tiffany CHW, Hung RKW, Angela KWC, Man KS, Man SRL, Tsoi VYK. PMID: 42537885 [PubMed - as supplied by publisher]
	Final analysis of the FeDeriCa phase III study: long-term efficacy, safety and pharmacokinetics of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection, plus chemotherapy, in HER2-positive early breast cancer. ESMO Open Jackisch C, Im SA, Mattar A, Colomer R, Stroyakovskiy D, Nowecki Z, De Laurentiis M, Pierga JY, Jung KH, Schem C, Heeson S, Yan I, Wang B, Restuccia E, Tan AR. PMID: 42537585 [PubMed - as supplied by publisher]
	Evaluating the Efficacy of Neoadjuvant Endocrine Therapy in HER2-Low Versus HER2-Negative Breast Cancer. Clin Breast Cancer Chong EG, Guo M, Bera K, Castillo D, Wu P. PMID: 42537448 [PubMed - as supplied by publisher]
	MD-Mamba: A multi-scale dilated state-space network for breast cancer histopathology image classification. Transl Oncol Liu G, Luo S, Wu C, Liu Y, Shi C. PMID: 42537429 [PubMed - as supplied by publisher]
	Correspondence on "Reconsidering the control arm in hyperthermic intra-peritoneal chemotherapy trials for epithelial ovarian cancer: are we comparing equivalent chemotherapy exposure?" by Poonyakanok et al. Int J Gynecol Cancer Kim JH, Quaranta M, Lim MC. PMID: 42538281 [PubMed - as supplied by publisher]
	Three-dimensional cell cultures as an in vitro tool for ovarian cancer modeling and natural product discovery. Biomed Pharmacother Aal MCE, Fioretto MN, da Silva TD, Guimarães IC, Goldoni ACS, Rios VLAS, Chuffa LGA, Delella FK. PMID: 42537397 [PubMed - as supplied by publisher]
	RECIST 1.1 and PERCIST for response assessment in metastatic breast cancer: feasibility and agreement in a realâ€‘world retrospective cohort study. Eur J Radiol Andersson VL, Johnson K, Skarping I. PMID: 42537342 [PubMed - as supplied by publisher]
	Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study. J Med Internet Res Terada M, Tahara RK, Wanifuchi-Endo Y, Asano T, Horisawa N, Nozawa K, Isogai A, Kureyama N, Kawahara H, Kotani M, Tanaka Y, Mizumoto M, Fushimi A, Yamashita N, Iwase M, Iesato A, Toyama T. PMID: 42537013 [PubMed - indexed for MEDLINE]
	Development and diagnostic performance of a modified O-RADS model incorporating septa number and blood flow for adnexal lesions. J Obstet Gynaecol Zhao N, Che D, Hu X. PMID: 42536923 [PubMed - indexed for MEDLINE]
	Gastric dose-volume parameters and toxicity in left-sided breast radiotherapy: A single-center retrospective comparison of helical tomotherapy and 3-dimensional field-in-field techniques. Medicine (Baltimore) Çini N, Tepetam H, Özcan AK, Gedik D, Karabulut Gül . PMID: 42536588 [PubMed - indexed for MEDLINE]
	Comparative efficacy of various exercise modalities on sleep quality in breast cancer survivors after primary treatment: A systematic review and dose-response network meta-analysis. Medicine (Baltimore) Li H, Dong S, Cheng Y. PMID: 42536584 [PubMed - indexed for MEDLINE]
	Inflammatory response and immunological alteration in polycystic ovary syndrome: An integrative case-control study. Mol Biol Rep Atheeb AK, Hussein SZ. PMID: 42536282 [PubMed - indexed for MEDLINE]
	Variant-specific contributions of CYP21A2 and CYP11B1 to the clinical and hormonal heterogeneity of polyendocrine metabolic ovarian syndrome phenotypes. Mol Biol Rep Polat S, Simsek Y. PMID: 42536251 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial. Ann Surg Oncol Tseng J, Dimitroff K, Sauder CAM, Chien AJ, Ahmed KA, Allen LF, Arciero CA, Burke EE, Chandler JM, Jordan JE, Golshan M, Gutnik LA, Jaskowiak NT, Hewitt KC, Howard-McNatt M, Ito F, Kang IM, Kesmodel SB, Kuerrer HM, Lee MC, Moran MC, Postlewait LM, Prionas ND, Rao R, Reyna CR, Schwer A, Taunk NK, Tchou J, Wallace AM, Li TJ, Perlmutter J, DeMichele AM, Yee D, Hylton NM, Van't Veer LJ, Rugo HS, Symmans WF, Shatsky RA, Isaacs CJD, Yau C, Esserman LJ, Boughey JC, Mukhtar RA. PMID: 42536241 [PubMed - as supplied by publisher]
	Machine learning and cox model-based prediction of CDK4/6 inhibitor outcomes in HR+/HER2â€‰-â€‰metastatic breast cancer: a multicenter real-world study. Breast Cancer Res Treat Liu B, Wu T, Ding S, Liu X, Zeng X, Liu Z, Lu K, She J, Chen J, Tian H, Tong Q, Tang K, Yu J, Wang J, Ding L, Li Y, Peng L, Zhou Q, Zhou H, Chao T, Ouyang Q, Xie N. PMID: 42536225 [PubMed - indexed for MEDLINE]
	Factors Associated With the Use of the Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology (LETSGO) mHealth App in Routine Follow-Up After Gynecologic Cancer Treatment: Observational Study. JMIR Cancer Tarabar Z, Børøsund E, H Fosstveit S, Berntsen S, Hagen M, Vistad I. PMID: 42536057 [PubMed - indexed for MEDLINE]
	Differences in age at diagnosis of breast cancer largely attributable to different age structures. Oncologist Malagón T. PMID: 42535911 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 333030

Seite 1 von 16652

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung